Literature DB >> 15951185

Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode.

Yoshiyasu Baba1, Nozomu Hirukawa, Mikiko Sodeoka.   

Abstract

Cantharidin is well known as a potent serine/threonine protein phosphatase 1 and 2A (PP1 and PP2A) inhibitor, with less potent inhibitory activity for PP2B, which regulates T-cell proliferation. We synthesized and evaluated four optically pure stereoisomers of 1-substituted norcantharidin analogues. The absolute stereochemistry of each stereoisomer was determined based on X-ray crystal structure analysis. Remarkably, optically active cantharidin analogues having (1S)-configuration showed selective inhibition of PP2B, without inhibiting PP1 or PP2A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951185     DOI: 10.1016/j.bmc.2005.05.013

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Crystallization and preliminary crystallographic study of a trypsin-resistant catalytic domain of human calcineurin.

Authors:  Lei Jin; Michael H A Roehrl; Li Xiao; Xiuyun He; Haibin Li; Linhu Ge; Bingyi Shi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-04-21

Review 2.  Targeting protein serine/threonine phosphatases for drug development.

Authors:  Jamie L McConnell; Brian E Wadzinski
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

Review 3.  Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  Bioorg Med Chem       Date:  2021-01-09       Impact factor: 3.641

4.  Antiparasitic Properties of Cantharidin and the Blister Beetle Berberomeloe majalis (Coleoptera: Meloidae).

Authors:  Douglas W Whitman; Maria Fe Andrés; Rafael A Martínez-Díaz; Alexandra Ibáñez-Escribano; A Sonia Olmeda; Azucena González-Coloma
Journal:  Toxins (Basel)       Date:  2019-04-22       Impact factor: 4.546

5.  Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?

Authors:  Matthias Sieber; Ria Baumgrass
Journal:  Cell Commun Signal       Date:  2009-10-27       Impact factor: 5.712

6.  N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.

Authors:  Ming-Che Chang; Jin-Yi Wu; Hui-Fen Liao; Yu-Jen Chen; Cheng-Deng Kuo
Journal:  Anticancer Drugs       Date:  2015-11       Impact factor: 2.248

7.  In Silico Characterization of Calcineurin from Pathogenic Obligate Intracellular Trypanosomatids: Potential New Biological Roles.

Authors:  Patricio R Orrego; Mayela Serrano-Rodríguez; Mauro Cortez; Jorge E Araya
Journal:  Biomolecules       Date:  2021-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.